CJEM Articles: Urbain Ip
Displaying 1-4 of 4 results
-
March
2012
14
2
Amanda Hanson, Andrew Healey, Guy Hebert, Mark Mensour, Michael Woo, Pierre Mikhail, Ryan J. Henneberry, Steve Miller, Steve Socransky, Urbain Ip
-
March
2012
14
2
Amanda Hanson, Andrew Healey, Guy Hebert, Mark Mensour, Michael Woo, Pierre Mikhail, Ryan J. Henneberry, Steve Miller, Steve Socransky, Urbain Ip
-
January
2000
2
1
Anurag Saincher, Urbain Ip
Objective: To assess the safety of pediatric procedural sedation performed by emergency physicians working within a structured sedation protocol.
Methods: A retrospective review of all children undergoing emergency department (ED) procedural sedation during a 2-year period after the institution of a structured sedation protocol.
Results: 167 children underwent procedural sedation, primarily for orthopedic manipulation, wound management and foreign body removal. Of these, 82% received ketamine, 17% received fentanyl and midazolam and 1% received midazolam alone. Sedation was adequate in all but 6 patients, who required supplemental ketamine for orthopedic manipulation. Vomiting after arousal occurred in 17 children (10%), but no episodes of clinical aspiration occurred. One child became agitated during recovery and another experienced a transient visual hallucination. There were no cases of laryngospasm, apnea or cardiorespiratory compromise, and no mortality or significant morbidity occurred.
Conclusion: Emergency physicians using a structured sedation protocol can safely perform ED pediatric procedural sedation. Where intravenous access is not already present, intramuscular ketamine, administered in the doses described, is a safe and effective agent for pediatric sedation. -
July
1999
1
2
Urbain Ip

